Aptuit LLC and Axxam SpA announce Strategic Alliance for Integrated Drug Discovery Services.
Commence major integrated discovery program for large Pharma sponsor
Greenwich, CT and Milan (Italy) – April 14, 2015 – Aptuit LLC, a premier global drug discovery and development CRO and Axxam SpA, a leading discovery company with expertise in target biology and a broad range of early phase discovery solutions, announced a strategic alliance to provide comprehensive and integrated services from gene to high quality candidates and beyond. This partnership will allow the companies to offer the best-in-class fully integrated drug discovery and development services, supported by a culture of scientific excellence and innovation.
Aptuit and Axxam are also delighted to announce that the partnership has already resulted in the commencement of the first significant joint integrated project with a large pharma sponsor.